Evidence map›Paper›PMID 25762722›Full record

ArticleThe Journal of biological chemistry2015

Group VIA Phospholipase A2 (iPLA2β) Modulates Bcl-x 5'-Splice Site Selection and Suppresses Anti-apoptotic Bcl-x(L) in β-Cells.

Suzanne E Barbour, Phuong T Nguyen, Margaret Park, Bhargavi Emani, Xiaoyong Lei, Mamatha Kambalapalli, Jacqueline C Shultz, Dayanjan Wijesinghe, Charles E Chalfant, Sasanka Ramanadham

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. iPLABiochimica et biophysica acta. Molecular and cell biology of lipids · 2019
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Suzanne E BarbourFrom the Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, Virginia 23298-0614.
Phuong T NguyenFrom the Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, Virginia 23298-0614.
Margaret ParkFrom the Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, Virginia 23298-0614.
Bhargavi EmaniFrom the Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, Virginia 23298-0614.
Xiaoyong Leithe Department of Cell, Developmental, and Integrative Biology and Comprehensive Diabetes Center, University of Alabama at Birmingham, Birmingham, Alabama 35294.
Mamatha KambalapalliFrom the Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, Virginia 23298-0614.
Jacqueline C ShultzFrom the Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, Virginia 23298-0614.
Dayanjan WijesingheFrom the Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, Virginia 23298-0614, the Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia 23249.
Charles E ChalfantFrom the Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, Virginia 23298-0614, the Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia 23249, the Massey Cancer Center, Richmond, Virginia 23298, and the Virginia Commonwealth University Reanimation Engineering Science Center, Richmond, Virginia 23298.
Sasanka Ramanadhamthe Department of Cell, Developmental, and Integrative Biology and Comprehensive Diabetes Center, University of Alabama at Birmingham, Birmingham, Alabama 35294, sramvem@uab.edu.
Virginia Commonwealth University · USUniversity of Alabama at Birmingham · USHunter Holmes McGuire VA Medical Center · US

Funding

Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Keri R Maher · 1985 to 2026
$51.0M
Center for Clinical and Translational ResearchUL1TR000058 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI MOELLER, FREDERICK GERARD · 2012 to 2015
$12.5M
The functional role of the cPLA2alpha/C1P interaction in sepsis resolutionR01HL125353 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI BROWN, RHODERICK E, CHALFANT, CHARLES E. · 2014 to 2018
$4.0M
The Role of Ceramide Kinase in Eicosanoid SynthesisR01HL072925 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI CHALFANT, CHARLES E. · 2004 to 2012
$3.1M
CALCIUM-INDEPENDENT PLA2BETA IN BETA-CELL APOPTOSISR01DK069455 · NIDDK · WASHINGTON UNIVERSITY · PI RAMANADHAM, SASANKA · 2004 to 2013
$2.7M
CONSTRUCTION OF SIGNALLING FACILITYC06RR017393 · NCRR · VIRGINIA COMMONWEALTH UNIVERSITY · PI MACRINA, FRANCIS L · 2002 to 2002
$2.0M
Center for Clinical and Translational ResearchKL2TR000057 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI MOELLER, FREDERICK GERARD · 2012 to 2014
$1.4M
Regulation of caspase 9 RNA splicing in NSCLC cancerR01CA154314 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI CHALFANT, CHARLES E. · 2011 to 2014
$1.2M
AB SCIEX 5500 QTRAP Mass Spectrometer for Lipidomics and Metabolomics ResearchS10OD010641 · OD · VIRGINIA COMMONWEALTH UNIVERSITY · PI CHALFANT, CHARLES E. · 2012 to 2012
$578k
Regulation of PAF Acetylhydrolase Expression by Oxidized PhospholipidsR21HL091388 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI BARBOUR, SUZANNE E · 2008 to 2009
$361k
The role of RNA splicing in non-small cell lung cancerI01BX001792 · VA · VA VETERANS ADMINISTRATION HOSPITAL · PI CHALFANT, CHARLES E. · 2013 to 2024
–
BLRD VA I01 BX001792NCATS NIH HHS KL2 TR000057NCATS NIH HHS UL1 TR000058NCI NIH HHS CA154314NCI NIH HHS P30 CA016059NCI NIH HHS R01 CA154314NCRR NIH HHS C06 RR017393NHLBI NIH HHS HL072925NHLBI NIH HHS HL91388NHLBI NIH HHS R01 HL072925NHLBI NIH HHS R01 HL125353NHLBI NIH HHS R21 HL091388NIDDK NIH HHS DK-69455NIDDK NIH HHS R01 DK069455NIH HHS NH1C06-RR17393NIH HHS S10 OD010641
6 · The paper itself

Abstract

Diabetes is a consequence of reduced β-cell function and mass, due to β-cell apoptosis. Endoplasmic reticulum (ER) stress is induced during β-cell apoptosis due to various stimuli, and our work indicates that group VIA phospholipase A2β (iPLA2β) participates in this process. Delineation of underlying mechanism(s) reveals that ER stress reduces the anti-apoptotic Bcl-x(L) protein in INS-1 cells. The Bcl-x pre-mRNA undergoes alternative pre-mRNA splicing to generate Bcl-x(L) or Bcl-x(S) mature mRNA. We show that both thapsigargin-induced and spontaneous ER stress are associated with reductions in the ratio of Bcl-x(L)/Bcl-x(S) mRNA in INS-1 and islet β-cells. However, chemical inactivation or knockdown of iPLA2β augments the Bcl-x(L)/Bcl-x(S) ratio. Furthermore, the ratio is lower in islets from islet-specific RIP-iPLA2β transgenic mice, whereas islets from global iPLA2β(-/-) mice exhibit the opposite phenotype. In view of our earlier reports that iPLA2β induces ceramide accumulation through neutral sphingomyelinase 2 and that ceramides shift the Bcl-x 5'-splice site (5'SS) selection in favor of Bcl-x(S), we investigated the potential link between Bcl-x splicing and the iPLA2β/ceramide axis. Exogenous C6-ceramide did not alter Bcl-x 5'SS selection in INS-1 cells, and neutral sphingomyelinase 2 inactivation only partially prevented the ER stress-induced shift in Bcl-x splicing. In contrast, 5(S)-hydroxytetraenoic acid augmented the ratio of Bcl-x(L)/Bcl-x(S) by 15.5-fold. Taken together, these data indicate that β-cell apoptosis is, in part, attributable to the modulation of 5'SS selection in the Bcl-x pre-mRNA by bioactive lipids modulated by iPLA2β.

Indexed as

RNA Splice SitesAnimalsApoptosisbcl-X ProteinCeramidesEndoplasmic Reticulum StressGroup VI Phospholipases A2HumansInsulin-Secreting CellsMiceMice, KnockoutRatsRNA SplicingSphingomyelin PhosphodiesteraseBcl2l1 protein, mousebcl-X ProteinCeramidesGroup VI Phospholipases A2Pla2g6 protein, mouseRNA Splice SitesSmpd3 protein, mouseSphingomyelin PhosphodiesteraseAlternative SplicingApoptosisBcl-xDiabetesPhospholipase ASignal Transductionβ-Cell

Identifiers

PMID25762722
PMCPMC4409262
OpenAlexW2030898919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.